2024-11-02 - Analysis Report
## Teladoc Health Inc. (TDOC) Stock Analysis Report

This report provides a comprehensive analysis of Teladoc Health Inc. (TDOC), a leading provider of virtual healthcare services, based on the provided data.

### 1. Performance Comparison with S&P 500 (VOO)

* **Company Overview:** Teladoc Health Inc. is a leading virtual healthcare company that provides telemedicine services, including virtual doctor visits, mental health care, and chronic care management.
* **Cumulative Return:** TDOC has a cumulative return of 51.72%, while the S&P 500 (VOO) has a cumulative return of 129.91%.
* **Deviation from S&P 500:** TDOC is currently lagging behind the S&P 500 by 78.19%. This places TDOC in the 1.15th percentile of its historical performance relative to the S&P 500, indicating it is significantly underperforming the market.

### 2. Recent Price Movement

* **Closing Price:** $9.0 (Last-market: $9.17)
* **5-Day Moving Average:** $8.91
* **20-Day Moving Average:** $9.1
* **60-Day Moving Average:** $8.22

The current price is slightly above the 5-day moving average, suggesting some short-term buying pressure. However, it is below both the 20-day and 60-day moving averages, indicating a potential downtrend.

### 3. Technical Indicators Analysis

* **RSI:** 47.45 - This indicates a neutral market sentiment, with no strong signals for buy or sell.
* **PPO:** -0.87 - This indicates a bearish trend, as the PPO is below the zero line.
* **Delta_Previous_Relative_Divergence:** 0.18 (+) - This signifies a short-term upward trend in the relative divergence, indicating potential upside momentum.
* **Expected Return:** 0.0% - Based on the current market conditions, long-term (2+ years) investors might not expect any significant outperformance compared to the S&P 500.

### 4. Recent Earnings and Outlook

| Date        | EPS  | Revenue |
|-------------|------|---------|
| 2024-10-31 | -0.19| $0.64 B$ |
| 2024-08-01 | -4.92| $0.64 B$ |
| 2024-04-26 | -0.49| $0.65 B$ |
| 2023-10-27 | -0.35| $0.66 B$ |
| 2024-10-31 | -0.35| $0.66 B$ |

The most recent earnings report showed a significant decline in EPS compared to the previous quarter, indicating a potential struggle for the company to maintain profitability. Further analysis of the earnings report, including comparing actual earnings to analyst estimates, would be crucial to assess the company's current financial health.

### 5. Financial Information Analysis

**1) Revenue and Profitability:**

| Quarter        | Revenue   | Profit Margin |
|-------------|----------|--------------|
| 2024-06-30  | $0.64B  | 70.73%      |
| 2024-03-31  | $0.65B  | 69.89%      |
| 2023-12-31  | $0.66B  | 70.72%      |
| 2023-09-30  | $0.66B  | 71.83%      |
| 2023-06-30  | $0.65B  | 70.79%      |

The company has maintained a consistent revenue stream, but profitability has been fluctuating. While the Profit Margin has remained high, the recent decline in EPS highlights potential issues with the company's cost management and operational efficiency.

**2) Capital and Profitability:**

| Quarter        | Equity    | ROE        |
|-------------|----------|------------|
| 2024-06-30  | $1.50B  | -55.77%    |
| 2024-03-31  | $2.29B  | -3.58%     |
| 2023-12-31  | $2.33B  | -1.24%     |
| 2023-09-30  | $2.29B  | -2.49%     |
| 2023-06-30  | $2.30B  | -2.84%     |

The negative ROE consistently highlights the company's struggle to generate profits from its equity investments. The significant decrease in equity in the most recent quarter further emphasizes the challenges faced by the company.

### 6. News and Recent Issues

* **Recent Earnings News:** Analyze recent earnings news from sources like Shacknews and others, focusing on the company's performance, guidance, and any related market reactions.
* **Recent Market Outlook:** Consult resources like FINBOLD for recent market outlooks, analyst opinions, and performance highlights.
* **Analyst Opinions and Performance Highlights:** Summarize analyst opinions about the company's future potential, including any buy, sell, or hold recommendations.

### 7. Conclusion

Teladoc Health Inc. (TDOC) is currently underperforming the market, with its stock price lagging behind the S&P 500. The company is facing challenges related to profitability and operational efficiency. While revenue has remained stable, the recent decline in EPS and equity raise concerns about the company's financial health. Further analysis of recent earnings reports and analyst opinions is necessary to understand the company's future prospects.

Investors considering investing in TDOC should carefully analyze the company's performance, recent news, and market outlook before making any investment decisions. 
